Of the markers of immunogenic cell death described in the Consensus guideline in 2015 [22], only HMGB1 can be measured in blood serum and plasma, as adenosine triphosphate (ATP) acts in the tumor microenvironment and calreticulin is exposed on tumor cells. The gene discussed is HMGB1; the disease is neoplasm.